Walleye Capital LLC Gh Research PLC Transaction History

Walleye Capital LLC

  • $46.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$10.5 - $14.81 $672,441 - $948,462
-64,042 Reduced 72.83%
23,896 $278,000
Q1 2024

May 15, 2024
BUY
$5.34 - $11.09 $469,588 - $975,232
87,938 New
87,938 $937,000
Q4 2021

Mar 03, 2022
SELL
$14.1 - $27.9 $574,546 - $1.14 Million
-40,748 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$16.51 - $23.68 $732,251 - $1.05 Million
-44,352 Reduced 52.12%
40,748 $899,000
Q2 2021

Aug 16, 2021
BUY
$19.25 - $21.73 $1.64 Million - $1.85 Million
85,100 New
85,100 $1.85 Million

Others Institutions Holding GHRS

# of Institutions
32
Shares Held
27.8M
Call Options Held
2.8K
Put Options Held
3.8K
View Full List

About GH Research PLC

GHRS Quotes by TradingView
  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $380M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email